Stanford University
Showing 11,001-11,010 of 35,030 Results
-
Angel Gunaman
Office Aide, Contingent
Undergraduate, Management Science and Engineering
Undergraduate, Mechanical EngineeringBioI'm a Mechanical Engineering major at Stanford, concentrating in Product Realization and minoring in Management Science & Engineering. I'm passionate about building meaningful technology and have experience in engineering research, product development, and public sector infrastructure.
-
Susanna Gunamany
Postdoctoral Scholar, Urology
BioDr. Gunamany received her PhD in Public Health from the Indian Institute of Technology (IIT) Gandhinagar. Before her doctoral studies, she earned a Master of Public Health (MPH) degree from the Jawaharlal Institute of Postgraduate Medical Education and Research (JIPMER), India, and a Bachelor of Science from the University of Kerala.
Dr. Gunamany's scholarly pursuits revolve around the convergence of health and technology, with a specific emphasis on mobile health (mHealth) and its potential for improving healthcare delivery and access. Broadening her research scope, she is interested in health disparities and inequalities research, focusing on marginalized populations and the intricate interplay of social, economic, and environmental factors influencing health outcomes. -
Ruwan Gunaratne
Instructor, Medicine - Hematology
BioRuwan Gunaratne, MD, PhD is an Instructor in Hematology at Stanford University School of Medicine and a board-certified hematologist-oncologist with a clinical focus on acute myeloid leukemia (AML), myelodysplastic syndromes (MDS), and myeloproliferative neoplasms (MPNs). His clinical and translational research centers on improving disease monitoring in myeloid cancers using personalized circulating tumor DNA (ctDNA) profiling, a blood-based approach designed to more sensitively track measurable residual disease (MRD), assess treatment response, refine risk stratification, and detect relapse earlier across the myeloid disease spectrum. Dr. Gunaratne’s work has been recognized with awards from the American Society of Hematology and the Stanford Cancer Institute, and he is actively committed to advancing precision medicine approaches for patients with myeloid malignancies.
